Paul V. Maier

Insider Reports History

Entity
Individual
Location
3595 John Hopkins Court, San Diego, CA
Signature
/s/ Russell Kern, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul V. Maier:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. Director Ordinary Shares 85K $786K $9.24 Jun 7, 2023 Direct
International Stem Cell CORP Director Stock Option (Right to Buy) 361K Jun 11, 2024 Direct
Eton Pharmaceuticals, Inc. Director Stock Option (Right to buy) 165K Feb 13, 2024 Direct
Ambrx Biopharma, Inc. Director Restricted Stock Units 0 Mar 7, 2024 Direct
Ambrx Biopharma, Inc. Director Option to Purchase Common Stock 0 Mar 7, 2024 Direct

Insider Reports Filed by Paul V. Maier

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ISCO.OB International Stem Cell CORP Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
AMAM Ambrx Biopharma, Inc. Mar 7, 2024 3 $0 4 Mar 7, 2024 Director
ETON Eton Pharmaceuticals, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director
ISCO International Stem Cell CORP Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
AMAM Ambrx Biopharma Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
ETON Eton Pharmaceuticals, Inc. Mar 3, 2023 1 $0 4 Mar 3, 2023 Director
AMAM Ambrx Biopharma Inc. Jan 27, 2023 4 $0 4 Jan 31, 2023 Director
AMAM Ambrx Biopharma Inc. Jan 1, 2023 0 $0 3 Jan 3, 2023 Director
ISCO International Stem Cell CORP Jun 9, 2022 2 $0 4 Jun 10, 2022 Director
ETON Eton Pharmaceuticals, Inc. Feb 7, 2022 1 $0 4 Feb 28, 2022 Director
ISCO International Stem Cell CORP Jun 9, 2021 2 $0 4 Jun 11, 2021 Director